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Introduction: Laparoscopic resection is widely used in the management of
colorectal cancer; however there is limited data regarding long-term outcomes,
particularly regarding rectal cancer. This study presents the long-term follow
up of the MRC-CLASICC trial of conventional versus laparoscopic surgery in
the treatment of colorectal cancer.
Methods: A total of 794 patients from 27 UK centres were randomised to
laparoscopic or open surgery in a 2:1 ratio between 1996 and 2002. Longterm
follow-up data involving intention-to-treat and actual treatment groups
was analysed to determine differences in survival outcomes and recurrences.
Survival and recurrence data were compared usingKaplan-Meier and cumulative
incidence function curves respectively, and tested using log-rank andWilcoxon
rank-sum tests.
Results: Median follow-up of all patients was 62.9 (IQR: 22.9-92.8) months.
For all patientsmedianOSwas 85.1 (95% CI 72.7-105.7) and 73.6 (95% CI 64.3-
89.5) months, whereas DFS was 94.8 (95% CI 74.2-108.7) and 70.6 (95% CI
55.0-85.5) months for colon and rectal cancer respectively, with no difference by
randomised procedure for either OS (p=0.78) or DFS (P=0.59). Colon cancer
patients experienced significantly worse OS (P=0.0005) and DFS (P=0.0068)
following conversion. No significant difference in recurrences were observed
by randomised procedure; however at 10 years right-sided local recurrence
was increased (14.7%) compared to left-sided (5.2%), P=0.019. Rectal cancer
patients experienced significantly improved early survival with laparoscopic
surgery, Wilcoxon P=0.0071.
Conclusions: Long-term results continue to support the use of laparoscopic
surgery for colon and rectal cancer. Trends in local recurrence warrant further
investigation.
Take-home message: Laparoscopic surgery is a safe alternative to
conventional open surgery in the treatment of both colon and rectal cancer
in suitable patients.
